•
Sep 30, 2022

Avidity Biosciences Q3 2022 Earnings Report

Total Revenue
$2.48M
Previous year: $2.16M
+14.7%
EPS
-$0.82
Previous year: -$0.68
+20.6%
Gross Profit
$2.08M
Previous year: -$22.7M
-109.2%
Cash and Equivalents
$144M
Previous year: $410M
-65.0%
Free Cash Flow
-$31.9M
Previous year: -$21.6M
+47.6%
Total Assets
$431M
Previous year: $426M
+1.1%

Avidity Biosciences

Avidity Biosciences